Advertisement
Canada markets open in 2 hours 25 minutes
  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CAD/USD

    0.7264
    +0.0001 (+0.01%)
     
  • CRUDE OIL

    82.35
    -0.38 (-0.46%)
     
  • Bitcoin CAD

    89,433.04
    +3,898.04 (+4.56%)
     
  • CMC Crypto 200

    1,330.65
    +18.03 (+1.39%)
     
  • GOLD FUTURES

    2,397.20
    -0.80 (-0.03%)
     
  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     
  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     
  • NASDAQ futures

    17,423.00
    -124.25 (-0.71%)
     
  • VOLATILITY

    19.38
    +1.38 (+7.68%)
     
  • FTSE

    7,832.28
    -44.77 (-0.57%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6817
    -0.0004 (-0.06%)
     

Dentsply Sirona’s Segments: Q2 2018 Performance

Dentsply Sirona’s Segments: Q2 2018 Performance

Since its second-quarter earnings release on July 7, Dentsply Sirona (XRAY) stock has plummeted ~20%. In this series, we’ll explore its financial performance, how its segments are performing, its recent acquisitions, its valuation metrics, and what analysts expect in the coming months. Dentsply Sirona is a leading global manufacturer of professional dental products and technologies.